COV - Stock Quote for Covidien plc

|CustomizeCOV quote (NYSE Exchange)

46.80 +0.66 +1.43%fyi
After Hours: 46.80 unch/unch Vol. 44,434
Previous Close	46.14	Bid	45.44
Open	46.29	Bid Size	100
Day's High	46.89	Ask	47.66
Day's Low	45.84	Ask Size	100
Volume	3.13 Mil	52 Week High	46.75
Avg. Daily Vol. (13 wk.)	2.63 Mil	52 Week Low	27.27

COV Intraday Chart

5d 1m 3m 1y 3y 5y 10y

Beta	0.91
Dividend & Yield	0.72 (1.56%)
Earnings/Share	1.79
Forward P/E	12.89
Market Cap.	23.37 Bil
P/E	26.29
Return on Equity	11.46
Total Shares Out.	499.30 Mil

Quotes delayed 15 min unless otherwise indicated

Last trade (extended hours) 4:22 PM ET Financial data in U.S. dollars

Your latest quotes: FUD, BRS, GCC, DTV, COV, JNJ

News about COV

Market Report -- In Play (COV) 11/20/2009 Briefing.com
Covidien says FDA extends Exalgo review 11/20/2009 Associated Press
Covidien raises fiscal 2010 revenue growth outlook 11/17/2009 Associated Press
Covidien 4Q profit down 86 pct. as expenses rise 11/17/2009 Associated Press
View all COV news

Press releases

FDA Extends Review of NDA for Exalgo™ 11/20/2009 Business Wire
Covidien Reports Fourth-Quarter and Fiscal 2009 Results 11/17/2009 Business Wire
View all COV news

News from the Web

Healthy Monday for Healthcare Yesterday At TheStreet.com
UPDATE 1-Covidien says FDA extends review of opiod pain drug 11/20/2009 At Thomson Reuters
Covidien Rises on Improved '10 View 11/17/2009 At Barron's
Covidien quarterly net income drops 86% 11/17/2009 At MarketWatch
View all COV news

Videos about COV

Covidien Raises 2010 Sales Outlook

Rich Meelia, president and CEO of medical device maker Covidien, discusses his company's earnings and outlook.

more...

From Our Sponsors

Stock ratings

	Community Stock Ratings
	CAPS Rating:

333 users rated this stock

No stock rating information is available for this stock at this time.

Analyst recommendation

Recommendation: Moderate Buy

View analyst ratings

More information for COV

Financial highlights

Sales*	10.68 Bil
Income*	902.00 Mil
Sales Growth*	+3.10%
Income Growth*	-87.10%
Net Profit Margin	8.45%
Debt/Equity Ratio	0.37

* last 12 months

More financial information

Funds that own COV

No funds own this stock.

Market update 6:52pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news

Market Talk With Jim Jubak message board

Go to the Market Talk With Jim Jubak message board

Data providers
Free Real-Time quotes provided by BATS Exchange, Inc.
Analyst Recommendations data provided by Zacks.com.
Quotes supplied by Interactive Data Real-Time Services.
StockScouter data provided by Gradient Analytics, Inc.

Page generated 9:52 PM Eastern Time